Estey, E <br/><br/>
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  Mar 1993 
 - 343-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199309148532  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Diseases--chemically induced<br/>Bone Marrow Transplantation<br/>Colitis--chemically induced<br/>Combined Modality Therapy<br/>Conjunctivitis--chemically induced<br/>Cytarabine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Pancreatitis--chemically induced<br/>Peripheral Nervous System Diseases--chemically induced<br/>Remission Induction<br/>Salvage Therapy<br/>Treatment Outcome<br/>Vidarabine--administration & dosage